In this issue:
Fracture risk/patterns after bariatric surgery
Genetic association with obesity greater in more recently born cohorts
Liraglutide and CV outcomes in type 2 diabetes
Empagliflozin and kidney disease progression in type 2 diabetes
Intensive treatment and severe hypoglycaemia in type 2 diabetes
Insulin-induced weight gain and CV risk factors
Antidiabetics and HF, CV disease and all-cause mortality risks
Text messages support weight loss in prediabetes
Probiotics for managing type 2 diabetes
‘The Biggest Loser(s)’ 6 years on
Please login below to download this issue (PDF)